Tag: Japan

LINC 2018 data highlight IN.PACT Admiral as safe and effective treatment...

Medtronic added to its body of clinical evidence supporting the IN.PACT Admiral drug-coated balloon with new presentations that demonstrated durable and consistent clinical outcomes...

Endologix announces collaboration agreements with Japan Lifeline for development and commercialisation...

Endologix has signed a joint research and development agreement, as well as an exclusive distribution agreement, with Japan Lifeline (JLL) pertaining to the development...

Promising 12- and 24-month East Asian experiences for drug-coated balloons

Results from two Asian studies presented at LINC 2017 (24–27 January, Leipzig, Germany), show encouraging outcomes for drug-coated balloon versus percutaneous transluminal angioplasty treatment...

Japanese IN.PACT SFA study demonstrates clinical outcomes consistent with other trials

The one-year clinical outcomes from the MDT-2113 IN.PACT SFA Japan trial have been released. The data was recently presented by Osamu Iida, Kansai Rosai...
Lombard Intelliflex

Fifteen Japanese Lombard Aorfix procedures with Intelliflex LP delivery system successfully...

Physicians in Japan have successfully treated the first 15 patients using Lombard’s new Intelliflex LP delivery system for the Aorfix endovascular stent graft since...
Lombard Intelliflex

Lombard Medical gets Japanese approval for IntelliFlex LP delivery system

Lombard Medical has announced approval from the Japanese Ministry of Health, Labour and Welfare for its IntelliFlex low-profile (LP) delivery system for the Aorfix...

One-year Japanese results support use of the Viabahn endoprosthesis to treat...

Gore has announced positive results from a prospective, multicentre investigational device exemption (IDE) clinical study of the Viabahn endoprosthesis with heparin bioactive surface in...